Trials
Search / Trial NCT06420622

INDIcators for Clarifying the bAckground of exTreme Obesity in childRen

Launched by UNIVERSITY OF LEIPZIG · May 14, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

The INDIcators trial is a study aimed at understanding the genetic factors that contribute to extreme obesity in children. Researchers are collecting saliva samples and asking families to complete short online questionnaires about their family history, physical traits, and eating behaviors. The study focuses on children aged 0 to 18 who have a body mass index (BMI) that is significantly higher than most of their peers, specifically those in the top 0.5% for their age. Participants will be recruited from medical centers in Germany.

To be eligible for the study, children must be older than 5 years and have a BMI that meets certain high thresholds. Children who have a known medical reason for their obesity will not be included. If you or your child participates, you can expect to have a telemedical consultation with a study doctor who will explain the study details. This research could provide valuable insights into childhood obesity and help improve future treatments.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Test subjects older 5 years:
  • BMI SDS between 0-5 years \> 1.881 (= p97) BMI SDS between 5 and 18 \>2.567 (=p99.5) Parents and subjects agree that the study information will be provided during a telemedical consultation by the study physician
  • Exclusion Criteria:
  • Known cause of servere early obesity

About University Of Leipzig

The University of Leipzig is a renowned academic institution in Germany, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials that aim to enhance patient care and contribute to the understanding of various health conditions. Its research initiatives are supported by state-of-the-art facilities and a diverse team of experts, positioning the University of Leipzig as a leader in the field of clinical research and a vital contributor to the global medical community.

Locations

Leipzig, Saxony, Germany

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0